DEXA Bone Density Analysis of the CoreHip® Prosthesis System
- Conditions
- Primary OsteoarthritisCartilage DegenerationOsteoarthritis, HipInflammatory ArthritisOsteonecrosis of Femoral HeadTraumatic Disorder
- Interventions
- Device: Primary hip replacement with cementless stem
- Registration Number
- NCT06632301
- Lead Sponsor
- Aesculap AG
- Brief Summary
The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.
- Detailed Description
Additional diagnostic examination: DEXA-Analysis. A DEXA scan is an imaging test that measures bone density (strength). The results can provide helpful details about risk for osteoporosis (bone loss) and fractures. Furthermore we would like to find out more about stress shielding processes around our prosthesis.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 40
- Unilateral hip osteoarthritis
- Indication for CoreHip Standard hip stem according to preoperative planning
- Written Informed Consent
- Age 35-85 years
- According to the assessment of the study doctor, the patient is therapy compliant and able to attend the follow-up visits
- Femoral neck fractures
- Pregnancy
- BMI > 35
- History of femoral fracture or previous surgery on the same hip
- Metabolic bone disease, use of steroids or other drugs affecting bone metabolism
- Intraoperative bone cracks
- Severe osteoarthritis of the contralateral hip
- THA of the contralateral side or other event leading to restricted weight bearing during the study period
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description DEXA Primary hip replacement with cementless stem DEXA bone density analysis to analyze the loading concept of the CoreHip® Prosthesis System
- Primary Outcome Measures
Name Time Method Radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative Changes in bone mineral density (BMD) according to Gruen.
- Secondary Outcome Measures
Name Time Method Development of Forgotten Joint Score preoperative, at discharge (1 week postop) and 12 months postoperative The EQ-5D-5L score is a generic score used to document the well-being of the patient.
Clinical Results: Joint Function (Harris Hip Score) preoperative, at discharge (1 week postop) and 12 months postoperative The functional results of the operated hip will be assessed with the Harris Hip Score (HHS) and evaluated over time.
Development of Quality of Life (EQ-5D-5L) preoperative, at discharge (1 week postop) and 12 months postoperative The EQ-5D-5L score is a generic score used to document the well-being of the patient.
Development of Pain preoperative, at discharge (1 week postop) and 12 months postoperative Radiological changes in the diaphyseal bone density (DEXA BMD progression over time in all Gruen Zones (Zone 1-7)
Trial Locations
- Locations (1)
Medizinische Hochschule Hannover
🇩🇪Hannover, Germany